ReviewEndocrine-related cancer2021
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches.
Mark P Labrecque et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it